{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:10:31Z","timestamp":1781669431020,"version":"3.54.5"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Anxiety diagnoses have surged recently during and after the COVID-19 pandemic. Lorazepam is widely recognized for its efficacy in treatment of anxiety, as well as insomnia, etc. However, the long-term safety profile of lorazepam in extensive patient populations has not been thoroughly established.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study aims to evaluate the potential lorazepam-associated adverse events (AEs) using data mining of the Food and Drug Administration Adverse Event Reporting System (FAERS) of the United States, seeking to provide a guidance for the future therapeutic practices.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our study revealed drug abuse, suicide attempt, sopor, delirium, and psychotic disorder were among the most prevalent AEs linked to lorazepam. In addition to common AEs, we also found that patients using lorazepam may have the risk of abnormal fat metabolism, cardiac impairment, and immunosuppression-related disorders.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>In general, our research has unveiled novel AE signals and expanded our understanding of the safety profile of lorazepam in clinical practices, providing guidance for its rational use.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1465245","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T13:53:54Z","timestamp":1732283634000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Adverse event profile of lorazepam: a real-world pharmacovigilance study using the FDA adverse event reporting system database"],"prefix":"10.3389","volume":"15","author":[{"given":"Zhengkang","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.2165\/00003495-198121030-00001","article-title":"Lorazepam: a review of its clinical pharmacological properties and therapeutic uses","volume":"21","author":"Ameer","year":"1981","journal-title":"Drugs"},{"key":"B2","first-page":"62","article-title":"Nonmedical abuse of benzodiazepines in opiate-dependent patients in tehran, Iran","volume":"6","author":"Babakhanian","year":"2012","journal-title":"Iran. J. Psychiatry Behav. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/15622975.2022.2086295","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - version 3. Part I: anxiety disorders","volume":"24","author":"Bandelow","year":"2023","journal-title":"World J. Biol. Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000506868","article-title":"Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications","volume":"89","author":"Cosci","year":"2020","journal-title":"Psychother. Psychosom."},{"key":"B5","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/ijd.16987","article-title":"Lupus vulgaris: a narrative review","volume":"63","author":"Couppoussamy","year":"2024","journal-title":"Int. J. Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e46637","DOI":"10.2196\/46637","article-title":"Effectiveness of online and remote interventions for mental health in children, adolescents, and young adults after the onset of the COVID-19 pandemic: systematic review and meta-analysis","volume":"11","author":"Fischer-Grote","year":"2024","journal-title":"JMIR Ment. Health"},{"key":"B7","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1080\/15563650.2019.1674321","article-title":"Child and adolescent benzodiazepine exposure and overdose in the United States: 16 years of poison center data","volume":"58","author":"Friedrich","year":"2020","journal-title":"Clin. Toxicol. (Phila)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"115857","DOI":"10.1016\/j.psychres.2024.115857","article-title":"Risk of suicide attempts and intentional self-harm on alprazolam","volume":"335","author":"Gibbons","year":"2024","journal-title":"Psychiatry Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jaac.2023.11.002","article-title":"Editorial: the challenge of psychopharmacological treatment of anxiety among youth offspring of parents with bipolar disorder","volume":"63","author":"Goldstein","year":"2024","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"921422","DOI":"10.3389\/fphar.2022.921422","article-title":"Effect of stress ulcers prophylaxis, sedative and statin on ventilator-associated pneumonia: a retrospective analysis based on mimic database","volume":"13","author":"Kong","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1001\/jamapsychiatry.2017.1220","article-title":"Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia spectrum disorder: a randomized clinical trial","volume":"74","author":"Larsen","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"23cr03616","DOI":"10.4088\/PCC.23cr03616","article-title":"When lorazepam worsens delirium in your catatonic patient","volume":"26","author":"Midkiff","year":"2024","journal-title":"Prim. Care Companion CNS Disord."},{"key":"B13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jpsychires.2023.10.055","article-title":"Risk factors for abnormal glucose metabolism during antipsychotic treatment: a prospective cohort study","volume":"168","author":"Miyakoshi","year":"2023","journal-title":"J. Psychiatr. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1080\/00952990802308221","article-title":"Pilot study of lorazepam and tiagabine effects on sleep, motor learning, and impulsivity in cocaine abstinence","volume":"34","author":"Morgan","year":"2008","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"B15","first-page":"407","article-title":"Self-harm and suicide associated with benzodiazepine usage","volume":"57","author":"Neale","year":"2007","journal-title":"Br. J. Gen. Pract."},{"key":"B16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1089\/g4h.2023.0050","article-title":"Effects of cooperative, competitive, and solitary exergames on cognition and anxiety levels in children with developmental disabilities","volume":"12","author":"Nekar","year":"2023","journal-title":"Games Health J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s10620-005-1281-1","article-title":"Endoscopy in asymptomatic minidose aspirin consumers","volume":"50","author":"Niv","year":"2005","journal-title":"Dig. Dis. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jpsychires.2022.04.033","article-title":"Population-based signals of benzodiazepine drug interactions associated with unintentional traumatic injury","volume":"151","author":"Pham Nguyen","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1136557","DOI":"10.3389\/fpubh.2023.1136557","article-title":"Depression symptoms, anxiety, and stress among undergraduate entrance admission seeking students in Bangladesh: a cross-sectional study","volume":"11","author":"Rabby","year":"2023","journal-title":"Front. Public Health"},{"key":"B20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S2215-0366(22)00375-3","article-title":"Prevalence of post-traumatic stress disorder and common mental disorders in health-care workers in England during the COVID-19 pandemic: a two-phase cross-sectional study","volume":"10","author":"Scott","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"862508","DOI":"10.3389\/fphar.2022.862508","article-title":"Post-Marketing safety concerns with secukinumab: a disproportionality analysis of the FDA adverse event reporting system","volume":"13","author":"Shu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/s42255-023-00839-2","article-title":"The serotonin transporter sustains human brown adipose tissue thermogenesis","volume":"5","author":"Suchacki","year":"2023","journal-title":"Nat. Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jad.2024.02.055","article-title":"Patterns of unhealthy lifestyle and their associations with depressive and anxiety symptoms among Chinese young adults: a latent class analysis","volume":"352","author":"Tang","year":"2024","journal-title":"J. Affect Disord."},{"key":"B24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12016-024-08980-w","article-title":"A global view of pemphigus: geographical variations","volume":"66","author":"Timoteo","year":"2024","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.chc.2023.02.001","article-title":"Developmental epidemiology of pediatric anxiety disorders","volume":"32","author":"Warner","year":"2023","journal-title":"Child. Adolesc. Psychiatr. Clin. N. Am."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e28132","DOI":"10.1016\/j.heliyon.2024.e28132","article-title":"Novel insights into post-marketing adverse events associated with lenvatinib: a comprehensive analysis utilizing the FAERS database","volume":"10","author":"Yu","year":"2024","journal-title":"Heliyon"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/s41467-024-45477-8","article-title":"Glucocorticoids increase adiposity by stimulating Kruppel-like factor 9 expression in macrophages","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"B28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12916-024-03274-6","article-title":"Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database","volume":"22","author":"Zhou","year":"2024","journal-title":"BMC Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1465245\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T13:53:56Z","timestamp":1732283636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1465245\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":28,"alternative-id":["10.3389\/fphar.2024.1465245"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1465245","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"article-number":"1465245"}}